Orphan designation: Synthetic hypericin Treatment of cutaneous T-cell lymphoma, 28/07/2015 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 11 April 2024 - 14:15

Orphan designation: Synthetic hypericin Treatment of cutaneous T-cell lymphoma, 28/07/2015 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-15-1515

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters